US FDA approves AstraZeneca’s new breast cancer pill Etcamah: Dosage, high risk and side effects — All you need to know
The US Food and Drug Administration granted accelerated approval on Friday to a next-generation oral breast cancer agent developed by AstraZeneca Plc, marking
